Deutsche Bank raises Neurocrine Biosciences target price to $175 from $165
NBIX•Deutsche Bank raised its target price for Neurocrine Biosciences to $175 from $165.
Related News
EZGO announces 1-for-3 reverse share split effective Nov. 5, 2026
EZGO•
EverQuote, Inc.: Needham raises target price to $35 from $30
EVER•
Bandwidth hosts Reverb to showcase Super Intelligence communications innovations
BAND•
CACI wins five-year, $108 million U.S. Air Force contract to modernize financial operations
CACI•
BBVA Argentina redirects Class 50 bond proceeds to debt refinancing
BBAR•